Navigation Links
Inhibiting blood to save the brain

interaction between Mac-1 and fibrinogen after the first episode of paralysis using the fibrin peptide prevented subsequent relapses. It also prevented further microglia activation and damage to myelin in the diseased mice, allowing them to survive with improved motor function.

"Importantly, this approach blocks fibrin's interaction with microglia, but not with platelets, so clotting wouldn't be impacted," said Akassoglou, adding that this potential MS therapy might also have applications to other blood-brain barrier diseases where blood leakage and microglia activation is present such as spinal cord injury, Alzheimer's disease or stroke.


'"/>

Source:University of California - San Diego


Page: 1 2

Related biology news :

1. Hepatitis C therapy: Inhibiting newly discovered microDNA molecule
2. White blood cell waste disposal system plays critical regulatory role
3. Epstein-Barr virus protein crucial to its role in blood cancers
4. New insight into regulation of blood stem cells
5. Nano-bumps could help repair clogged blood vessels
6. First technology to remove prions that cause vCJD from blood launched
7. Breakthrough isolating embryo-quality stem cells from blood
8. Thai spice helps cut blood sugar swings
9. Study shows humans have ability to track odors, much like bloodhounds
10. Mad cow proteins successfully detected in blood
11. Unexpected lock and key mechanism found for the assembly of tumor blood vessels
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Inhibiting blood save the brain

(Date:3/12/2010)... management of soil and irrigation is a vital factor ... water balance of the vineyard on wine quality and ... In order to innovate in this area, the NEIKER-Tecnalia ... of temporary cover crop and different irrigation regimes for ... region on yield, vine vigour and grape and wine ...
(Date:3/11/2010)... Society for Microbiology (ASM) Raymond W. Sarber Award is ... at Juniata College, Huntington, PA, for his work on ... of the late Raymond W. Sarber and his ... , Johnson has spent the past two years ... He examined transposon insertion mutants with developmental defects using ...
(Date:3/11/2010)... the main vector of malaria have found ... act triggers two enzymes to form a network of ... this protein barrier, the researchers found, is part of ... commensal gut bacteria to grow without activating mosquito immune ... prevents the mosquito,s immune defense system from clearing ...
Breaking Biology News(10 mins):The use of cover crops in vineyards can help control the yield and quality of grapes and wine 2The use of cover crops in vineyards can help control the yield and quality of grapes and wine 3Barrier in mosquito midgut protects invading pathogens 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 15124 1Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 15124 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 15124 3Heska Announces Extension of Credit Agreement With Wells Fargo 6882 1Heska Announces Extension of Credit Agreement With Wells Fargo 6882 2Heska Announces Extension of Credit Agreement With Wells Fargo 6882 3News brief 3A Dermatologic infections in cancer patients treated with EGFRI therapy 62987 1
... University and the University of California, San Diego, have ... determines the patterns of fur coloration that camouflage mice ... work, published this week in the journal PLoS Biology, ... genetic changes have been linked to an organism,s ability ...
... an ironic twist, 11 countries that have avoided widespread ... being left out of an emerging carbon market intended ... A study published Tuesday in the Public Library of ... with low rates of deforestation (HFLD) nations could become ...
... Mich. Dont ever change isnt just a romantic ... among the creatures that produce scads of genetically identical ... creatures provide a chance to wonder about the clones ... their kin. ,In this weeks Proceedings of the National ...
Other Biology News:Interaction of just 2 genes governs coloration patterns in mice 2New study warns limited carbon market puts 20 percent of tropical forest at risk 2New study warns limited carbon market puts 20 percent of tropical forest at risk 3Clones on task serve greater good, evolutionary study shows 2
(Date:3/12/2010)... in medical device package, product and material testing, is taking strides ... Francis to division manager. , ... Minneapolis, MN (PRWEB) ... package, product and material testing, is taking strides to expand their ... manager. , , ,DDL has been helping medical device manufacturers ...
(Date:3/11/2010)... announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic ... ... , , ... ... ...
(Date:3/11/2010)... 11, 2010 Azur Pharma Limited ("Azur") today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan ... ... , ... ... ...
(Date:3/11/2010)... March 11 /PRNewswire/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing ... agreements with University Health Network (UHN) and The Hospital for Sick Children (SickKids) ... immunology programs in the areas of hematopoietic stem cell transplantation and cancer. , ... ... ...
Breaking Biology Technology:DDL Expands the Product & Material Testing Division 2DDL Expands the Product & Material Testing Division 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 2FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 5FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 6FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 7FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 8Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 2Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 3Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 4Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 5Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan 6Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 2Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 3
... Inc., 2000 Alfred Nobel Drive,Hercules, CA 94547 USA , ... Real-Time PCR , ... , in the technology and associated equipment have ... today relative to earlier protocols. One of the , ...
... Giles Cunnick and Wen Guo Jiang, Metastasis Research Group, University,Department of ... , Introduction ... of new lymphatic vessels. This , process ... to spreading by direct invasion and via the bloodstream, ...
... Qian Gao, Joella Blas, and Efthalia Gerasimopoulos, Bio-Rad Laboratories, Inc.,Hercules, CA 94547 USA ... Introduction , ... volume of sample. The assays are based on detection ... (xMAP technology) that have bound to each target protein. , ...
Other Biology Technology:The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 2The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 3The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 4The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 5The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 6The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 7The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 8Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 2Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 3Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 4Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 5Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays 2Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays 3Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays 4
RABBIT ANTI HUMAN APP (KP1 DOMAIN) Immunogen: Synthetic peptide composed of amino acids 292-312 from the KPI domain of human APP....
Request Info...
... provides all the materials necessary for the isolation ... antigen studies analysis. Kit Components: ... 5122) One bottle containing 220 mL of buffered ... (5X) - (Catalog No. 5113) One bottle containing ...
... use with suspension (non-adherent) cells, ... vacuum filtration or centrifugation to ... Compatible with 96-well GenePlate®. ... larger package sizes and contain ...
Biology Products: